Shopping Cart 0
Cart Subtotal
AED 0

Global Nonalcoholic Steatohepatitis (NASH) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543

Details

Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.

Scope of the Report:

This report studies the Nonalcoholic Steatohepatitis (NASH) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nonalcoholic Steatohepatitis (NASH) market by product type and applications/end industries.

NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.

At present, vitamin E & pioglitazone segment dominates the non-alcoholic steatohepatitis (NASH) market, due to efficacy.

Asia-Pacific presents lucrative opportunities for the key players operating in the non-alcoholic steatohepatitis (NASH) market. Some factors such as growth in diagnostic techniques, rapid rise in prevalence NASH, growth in economies, and increase in demand for NASH therapeutics drive the market growth in Asia-Pacific.

The global Nonalcoholic Steatohepatitis (NASH) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nonalcoholic Steatohepatitis (NASH).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Tobira Therapeutics

Cadila Healthcare

Conatus Pharmaceuticals

Galmed Pharmaceuticals

Gemphire Therapeutics

Genfit

Gilead Sciences

Intercept Pharmaceuticals

Novartis International

Shire

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Vitamin E & Pioglitazone

Ocaliva

Elafibranor

Selonsertib & Cenicriviroc

Market Segment by Applications, can be divided into

Hospital Pharmacy

Online Provider

Retail Pharmacy

READ MORE

Table Of Content

Scope

Table of Contents

1 Nonalcoholic Steatohepatitis (NASH) Market Overview

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)

1.2 Classification of Nonalcoholic Steatohepatitis (NASH) by Types

1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Comparison by Types (2017-2023)

1.2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Types in 2017

1.2.3 Vitamin E & Pioglitazone

1.2.4 Ocaliva

1.2.5 Elafibranor

1.2.6 Selonsertib & Cenicriviroc

1.3 Global Nonalcoholic Steatohepatitis (NASH) Market by Application

1.3.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacy

1.3.3 Online Provider

1.3.4 Retail Pharmacy

1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Regions

1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.5 Global Market Size of Nonalcoholic Steatohepatitis (NASH) (2013-2023)

2 Manufacturers Profiles

2.1 Tobira Therapeutics

2.1.1 Business Overview

2.1.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Cadila Healthcare

2.2.1 Business Overview

2.2.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Conatus Pharmaceuticals

2.3.1 Business Overview

2.3.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Galmed Pharmaceuticals

2.4.1 Business Overview

2.4.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Gemphire Therapeutics

2.5.1 Business Overview

2.5.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Genfit

2.6.1 Business Overview

2.6.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Gilead Sciences

2.7.1 Business Overview

2.7.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Intercept Pharmaceuticals

2.8.1 Business Overview

2.8.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Novartis International

2.9.1 Business Overview

2.9.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis International Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.10 Shire

2.10.1 Business Overview

2.10.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Shire Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nonalcoholic Steatohepatitis (NASH) Market Competition, by Players

3.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Nonalcoholic Steatohepatitis (NASH) Players Market Share

3.2.2 Top 10 Nonalcoholic Steatohepatitis (NASH) Players Market Share

3.3 Market Competition Trend

4 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions

4.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Regions

4.2 North America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.3 Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.5 South America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

5 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

5.1 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

5.2 USA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

5.3 Canada Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

5.4 Mexico Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

6.1 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

6.2 Germany Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.3 UK Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.4 France Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.5 Russia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.6 Italy Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

7.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

7.2 China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.3 Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.4 Korea Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.5 India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

8 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

8.1 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

8.2 Brazil Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

8.3 Argentina Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

8.4 Colombia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Nonalcoholic Steatohepatitis (NASH) by Countries

9.1 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.3 UAE Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.4 Egypt Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.6 South Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

10 Global Nonalcoholic Steatohepatitis (NASH) Market Segment by Type

10.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2013-2018)

10.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Type (2018-2023)

10.3 Vitamin E & Pioglitazone Revenue Growth Rate (2013-2023)

10.4 Ocaliva Revenue Growth Rate (2013-2023)

10.5 Elafibranor Revenue Growth Rate (2013-2023)

10.6 Selonsertib & Cenicriviroc Revenue Growth Rate (2013-2023)

11 Global Nonalcoholic Steatohepatitis (NASH) Market Segment by Application

11.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application (2013-2018)

11.2 Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacy Revenue Growth (2013-2018)

11.4 Online Provider Revenue Growth (2013-2018)

11.5 Retail Pharmacy Revenue Growth (2013-2018)

12 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2018-2023)

12.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2018-2023)

12.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Regions (2018-2023)

12.3 North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.4 Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.6 South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Nonalcoholic Steatohepatitis (NASH) Picture

Table Product Specifications of Nonalcoholic Steatohepatitis (NASH)

Table Global Nonalcoholic Steatohepatitis (NASH) and Revenue (Million USD) Market Split by Product Type

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Types in 2017

Figure Vitamin E & Pioglitazone Picture

Figure Ocaliva Picture

Figure Elafibranor Picture

Figure Selonsertib & Cenicriviroc Picture

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Application (2013-2023)

Figure Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Applications in 2017

Figure Hospital Pharmacy Picture

Figure Online Provider Picture

Figure Retail Pharmacy Picture

Table Global Market Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Table Tobira Therapeutics Basic Information, Manufacturing Base and Competitors

Table Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Cadila Healthcare Basic Information, Manufacturing Base and Competitors

Table Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Conatus Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Gemphire Therapeutics Basic Information, Manufacturing Base and Competitors

Table Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Genfit Basic Information, Manufacturing Base and Competitors

Table Genfit Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Sciences Basic Information, Manufacturing Base and Competitors

Table Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis International Basic Information, Manufacturing Base and Competitors

Table Novartis International Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Novartis International Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Shire Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Players (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players in 2016

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players in 2017

Figure Global Top 5 Players Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in 2017

Figure Global Top 10 Players Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in 2017

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Regions (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Regions (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Regions (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Regions in 2017

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

Table North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure USA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Canada Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Mexico Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure Germany Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure UK Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure France Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Russia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Italy Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Korea Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

Table South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure Brazil Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Argentina Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Colombia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure UAE Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Egypt Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Nigeria Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure South Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Type (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2017

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Forecast by Type (2018-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Type (2018-2023)

Figure Global Vitamin E & Pioglitazone Revenue Growth Rate (2013-2018)

Figure Global Ocaliva Revenue Growth Rate (2013-2018)

Figure Global Elafibranor Revenue Growth Rate (2013-2018)

Figure Global Selonsertib & Cenicriviroc Revenue Growth Rate (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Application (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application in 2017

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Forecast by Application (2018-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Application (2018-2023)

Figure Global Hospital Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Online Provider Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Tobira Therapeutics

Cadila Healthcare

Conatus Pharmaceuticals

Galmed Pharmaceuticals

Gemphire Therapeutics

Genfit

Gilead Sciences

Intercept Pharmaceuticals

Novartis International

Shire

Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.

Scope of the Report:

This report studies the Nonalcoholic Steatohepatitis (NASH) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nonalcoholic Steatohepatitis (NASH) market by product type and applications/end industries.

NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.

At present, vitamin E & pioglitazone segment dominates the non-alcoholic steatohepatitis (NASH) market, due to efficacy.

Asia-Pacific presents lucrative opportunities for the key players operating in the non-alcoholic steatohepatitis (NASH) market. Some factors such as growth in diagnostic techniques, rapid rise in prevalence NASH, growth in economies, and increase in demand for NASH therapeutics drive the market growth in Asia-Pacific.

The global Nonalcoholic Steatohepatitis (NASH) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nonalcoholic Steatohepatitis (NASH).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Tobira Therapeutics

Cadila Healthcare

Conatus Pharmaceuticals

Galmed Pharmaceuticals

Gemphire Therapeutics

Genfit

Gilead Sciences

Intercept Pharmaceuticals

Novartis International

Shire

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Vitamin E & Pioglitazone

Ocaliva

Elafibranor

Selonsertib & Cenicriviroc

Market Segment by Applications, can be divided into

Hospital Pharmacy

Online Provider

Retail Pharmacy

READ MORE

Scope

Table of Contents

1 Nonalcoholic Steatohepatitis (NASH) Market Overview

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)

1.2 Classification of Nonalcoholic Steatohepatitis (NASH) by Types

1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Comparison by Types (2017-2023)

1.2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Types in 2017

1.2.3 Vitamin E & Pioglitazone

1.2.4 Ocaliva

1.2.5 Elafibranor

1.2.6 Selonsertib & Cenicriviroc

1.3 Global Nonalcoholic Steatohepatitis (NASH) Market by Application

1.3.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacy

1.3.3 Online Provider

1.3.4 Retail Pharmacy

1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Regions

1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2023)

1.5 Global Market Size of Nonalcoholic Steatohepatitis (NASH) (2013-2023)

2 Manufacturers Profiles

2.1 Tobira Therapeutics

2.1.1 Business Overview

2.1.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Cadila Healthcare

2.2.1 Business Overview

2.2.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Conatus Pharmaceuticals

2.3.1 Business Overview

2.3.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Galmed Pharmaceuticals

2.4.1 Business Overview

2.4.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Gemphire Therapeutics

2.5.1 Business Overview

2.5.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Genfit

2.6.1 Business Overview

2.6.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Gilead Sciences

2.7.1 Business Overview

2.7.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Intercept Pharmaceuticals

2.8.1 Business Overview

2.8.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Novartis International

2.9.1 Business Overview

2.9.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis International Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

2.10 Shire

2.10.1 Business Overview

2.10.2 Nonalcoholic Steatohepatitis (NASH) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Shire Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nonalcoholic Steatohepatitis (NASH) Market Competition, by Players

3.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Nonalcoholic Steatohepatitis (NASH) Players Market Share

3.2.2 Top 10 Nonalcoholic Steatohepatitis (NASH) Players Market Share

3.3 Market Competition Trend

4 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions

4.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Regions

4.2 North America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.3 Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.5 South America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

5 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

5.1 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

5.2 USA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

5.3 Canada Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

5.4 Mexico Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

6.1 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

6.2 Germany Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.3 UK Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.4 France Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.5 Russia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

6.6 Italy Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

7.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

7.2 China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.3 Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.4 Korea Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.5 India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

8 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries

8.1 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

8.2 Brazil Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

8.3 Argentina Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

8.4 Colombia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Nonalcoholic Steatohepatitis (NASH) by Countries

9.1 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.3 UAE Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.4 Egypt Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

9.6 South Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

10 Global Nonalcoholic Steatohepatitis (NASH) Market Segment by Type

10.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2013-2018)

10.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Type (2018-2023)

10.3 Vitamin E & Pioglitazone Revenue Growth Rate (2013-2023)

10.4 Ocaliva Revenue Growth Rate (2013-2023)

10.5 Elafibranor Revenue Growth Rate (2013-2023)

10.6 Selonsertib & Cenicriviroc Revenue Growth Rate (2013-2023)

11 Global Nonalcoholic Steatohepatitis (NASH) Market Segment by Application

11.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application (2013-2018)

11.2 Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacy Revenue Growth (2013-2018)

11.4 Online Provider Revenue Growth (2013-2018)

11.5 Retail Pharmacy Revenue Growth (2013-2018)

12 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2018-2023)

12.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2018-2023)

12.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Regions (2018-2023)

12.3 North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.4 Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.6 South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Nonalcoholic Steatohepatitis (NASH) Picture

Table Product Specifications of Nonalcoholic Steatohepatitis (NASH)

Table Global Nonalcoholic Steatohepatitis (NASH) and Revenue (Million USD) Market Split by Product Type

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Types in 2017

Figure Vitamin E & Pioglitazone Picture

Figure Ocaliva Picture

Figure Elafibranor Picture

Figure Selonsertib & Cenicriviroc Picture

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Application (2013-2023)

Figure Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Applications in 2017

Figure Hospital Pharmacy Picture

Figure Online Provider Picture

Figure Retail Pharmacy Picture

Table Global Market Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2023)

Table Tobira Therapeutics Basic Information, Manufacturing Base and Competitors

Table Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Cadila Healthcare Basic Information, Manufacturing Base and Competitors

Table Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Conatus Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Gemphire Therapeutics Basic Information, Manufacturing Base and Competitors

Table Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Genfit Basic Information, Manufacturing Base and Competitors

Table Genfit Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Sciences Basic Information, Manufacturing Base and Competitors

Table Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis International Basic Information, Manufacturing Base and Competitors

Table Novartis International Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Novartis International Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Nonalcoholic Steatohepatitis (NASH) Type and Applications

Table Shire Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Players (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players in 2016

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players in 2017

Figure Global Top 5 Players Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in 2017

Figure Global Top 10 Players Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in 2017

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Regions (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Regions (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Regions (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Regions in 2017

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

Table North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure USA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Canada Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Mexico Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure Germany Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure UK Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure France Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Russia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Italy Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Korea Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)

Table South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure Brazil Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Argentina Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Colombia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure UAE Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Egypt Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure Nigeria Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Figure South Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Type (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2017

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Forecast by Type (2018-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Type (2018-2023)

Figure Global Vitamin E & Pioglitazone Revenue Growth Rate (2013-2018)

Figure Global Ocaliva Revenue Growth Rate (2013-2018)

Figure Global Elafibranor Revenue Growth Rate (2013-2018)

Figure Global Selonsertib & Cenicriviroc Revenue Growth Rate (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Application (2013-2018)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application in 2017

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Forecast by Application (2018-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Application (2018-2023)

Figure Global Hospital Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Online Provider Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2018-2023)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Tobira Therapeutics

Cadila Healthcare

Conatus Pharmaceuticals

Galmed Pharmaceuticals

Gemphire Therapeutics

Genfit

Gilead Sciences

Intercept Pharmaceuticals

Novartis International

Shire